Burg Simpson Eldredge Hersh & Jardine, Pc
Recent News About Burg Simpson Eldredge Hersh & Jardine, Pc View More
-
Abbvie wins another bellwether trial amid mass action over Androgel testosterone drug
A federal jury has handed a win to North Chicago-based drugmaker Abbvie, as it continues to seek to fend off a mass of legal claims accusing the company’s testosterone replacement therapy drug, Androgel, of causing heart attacks and other cardiovascular conditions. -
Jury declares Abbvie's Androgel didn't cause man's lung clots, Abbvie didn't falsely market medication
After split verdicts in two prior trials over alleged harmful side effects and alleged misleading marketing of its testosterone replacement drug led to questionable verdicts worth more than $140 million each, drugmaker Abbvie has scored a clean win in the latest jury review of a plaintiff’s claims over the promotion and health impacts of Androgel. -
Drugmaker Auxilium wins at jury in its first bellwether trial over testosterone therapy drug Testim
While their competitor AbbVie seeks to undo jury verdicts worth nearly $290 million over testosterone replacement therapy drugs, drugmaker Auxilium has received a clean bill from a jury in its first court test over claims it and other similar drugmakers should be made to pay for alleged misleading marketing that led men to take the drugs, and suffered heart attacks as a result. -
Judge: Testosterone replacement drug bellwether OK to proceed vs Testim maker Auxilium
After two federal juries delivered $140 million verdicts against AbbVie, competing drugmaker Auxilium will be headed to trial over claims its testosterone replacement therapy drug Testim caused heart attacks in men who took the drug to treat “off-label” conditions, spurred by what plaintiffs alleged was misleading marketing from drugmakers.